Skip to content

Clinical trials

Phase 2 Hepatitis C, Chronic trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C, Chronic Phase: Phase 2 Country / region: Taiwan Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20092
20101
20112
20131
20141
20151

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ainos, Inc. (f/k/a Amarillo Biosciences Inc.1
Debiopharm International SA1
Hoffmann-La Roche1
Novartis1
Novartis Pharmaceuticals1
Pfizer1
PharmaEssentia1
TCM Biotech International Corp.1
TaiGen Biotechnology Co., Ltd.1
TaiwanJ Pharmaceuticals Co., Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C, Chronic10
Hepatitis C3
Hepatitis1
Hepatitis, Chronic1
Recurrence1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.